Minor
AERIS · VENT-03 · Active Cutaneous Lupus Erythematosus With or Without Systemic Lupus Erythematosus
Primary completion pushed from Jul 2026 to Dec 2026
Also in this update: Completion pushed from Sep 2026 to Mar 2027
Ventus Therapeutics U.S., Inc.Phase 2 NCT07260877 Registry history of NCT07260877 on ClinicalTrials.gov (opens the registry)
Updated